A PHASE I ASSESSMENT OF MESENCHYMAL STEM CELLS FOR THE TREATMENT OF MULTIPLE SCLEROSIS

$2,418,169FY2010Department of the ArmyDOD

The Cleveland Clinic Foundation

Investigators